Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA authorizes phase II study of autologous adipose-derived mesenchymal stem cells in MS

July 29, 2021

First patients dosed in new studies of Xpovio in melanoma and myelofibrosis

July 29, 2021

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent PD-1/PD-L1 inhibitors

July 29, 2021

New RORgammaT agonists identified at Sunshine Lake Pharma

July 29, 2021

Chengdu Baiyu Pharmaceutical presents new tetrahydrocannabinol derivatives

July 29, 2021

DiosCURE enters licensing agreement for single-domain antibodies against SARS-CoV-2

July 28, 2021

Eccogene begins first-in-human study of ECC-0509 for NASH and osteoarthritis pain

July 28, 2021

University of Oxford tests vaccine against plague in phase I

July 28, 2021

Ipsen and BAKX Therapeutics partner on BKX-001

July 28, 2021

Mouse model shows targeting RagC GTPase could safely treat B-cell lymphomas

July 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...